134 related articles for article (PubMed ID: 6204368)
1. Antigenic characterization of poliovirus type 3 using monoclonal antibodies.
Ferguson M; Minor PD; Magrath DI; Spitz M; Schild GC
Rev Infect Dis; 1984; 6 Suppl 2():S510-3. PubMed ID: 6204368
[TBL] [Abstract][Full Text] [Related]
2. Antigenic analysis of poliovirus type 3 using monoclonal antibodies.
Ferguson M; Minor PD; Magrath DI; Schild GC
Dev Biol Stand; 1984; 57():151-5. PubMed ID: 6098495
[TBL] [Abstract][Full Text] [Related]
3. Neutralization epitopes on poliovirus type 3 particles: an analysis using monoclonal antibodies.
Ferguson M; Minor PD; Magrath DI; Qui YH; Spitz M; Schild GC
J Gen Virol; 1984 Jan; 65 ( Pt 1)():197-201. PubMed ID: 6198447
[TBL] [Abstract][Full Text] [Related]
4. Induction of neutralizing antibodies by poliovirus capsid polypeptides VP1, VP2 and VP3.
van der Marel P; Hazendonk TG; Henneke MA; van Wezel AL
Vaccine; 1983 Dec; 1(1):17-22. PubMed ID: 6099638
[TBL] [Abstract][Full Text] [Related]
5. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3.
Minor PD; Evans DM; Ferguson M; Schild GC; Westrop G; Almond JW
J Gen Virol; 1985 May; 66 ( Pt 5)():1159-65. PubMed ID: 2582084
[TBL] [Abstract][Full Text] [Related]
6. Detection by monoclonal antibodies of an antigenic determinant critical for poliovirus neutralization present on VP1 and on heat-inactivated virions.
Blondel B; Akacem O; Crainic R; Couillin P; Horodniceanu F
Virology; 1983 Apr; 126(2):707-10. PubMed ID: 6190311
[TBL] [Abstract][Full Text] [Related]
7. Immunochemical studies of polioviruses: identification of immunoreactive virus capsid polypeptides.
Thorpe R; Minor PD; Mackay A; Schild GC; Spitz M
J Gen Virol; 1982 Dec; 63(2):487-92. PubMed ID: 6185628
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies specific for the Sabin vaccine strain of poliovirus 3.
Ferguson M; Yi-hua Q; Minor PD; Magrath DI; Spitz M; Schild GC
Lancet; 1982 Jul; 2(8290):122-4. PubMed ID: 6123838
[TBL] [Abstract][Full Text] [Related]
9. Poliovirus Sabin type 1 neutralization epitopes recognized by immunoglobulin A monoclonal antibodies.
Fiore L; Ridolfi B; Genovese D; Buttinelli G; Lucioli S; Lahm A; Ruggeri FM
J Virol; 1997 Sep; 71(9):6905-12. PubMed ID: 9261417
[TBL] [Abstract][Full Text] [Related]
10. Antigenic sites of poliovirus type 3 eliciting IgA monoclonal antibodies in orally immunized mice.
Buttinelli G; Ruggeri FM; Marturano J; Novello F; Donati V; Fiore L
Virology; 2001 Mar; 281(2):265-71. PubMed ID: 11277698
[TBL] [Abstract][Full Text] [Related]
11. Application of monoclonal antibodies for the identification of the antigenic site for poliovirus neutralization.
Minor PD; Schild GC; Evans D; Ferguson M; Almond J
Dev Biol Stand; 1984; 57():171-5. PubMed ID: 6084608
[TBL] [Abstract][Full Text] [Related]
12. Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site.
Blondel B; Crainic R; Fichot O; Dufraisse G; Candrea A; Diamond D; Girard M; Horaud F
J Virol; 1986 Jan; 57(1):81-90. PubMed ID: 2416957
[TBL] [Abstract][Full Text] [Related]
13. Stabilization by host cell components and Mg2+ of the neutralization epitopes of poliovirus.
Rombaut B; Vrijsen R; Boeyé A
J Gen Virol; 1985 Feb; 66 ( Pt 2)():303-7. PubMed ID: 2578552
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to polioviruses. Production of specific monoclonal antibodies to the Sabin vaccine strains.
Osterhaus AD; van Wezel AL; van Steenis B; Drost GA; Hazendonk TG
Intervirology; 1981; 16(4):218-24. PubMed ID: 6177658
[TBL] [Abstract][Full Text] [Related]
15. Antigenic structure of polioviruses of serotypes 1, 2 and 3.
Minor PD; Ferguson M; Evans DM; Almond JW; Icenogle JP
J Gen Virol; 1986 Jul; 67 ( Pt 7)():1283-91. PubMed ID: 2425046
[TBL] [Abstract][Full Text] [Related]
16. Binding of neutralizing monoclonal antibodies to empty capsids of poliovirus can be blocked by monospecific antisera to structural polypeptides VP1 and VP2.
Uhlig H; Haardt F; Dernick R
Arch Virol; 1985; 83(3-4):295-303. PubMed ID: 2578787
[TBL] [Abstract][Full Text] [Related]
17. Use of monoclonal antibodies prepared with Sabin vaccine viruses for the characterization of poliovirus strains isolated in Canada.
Wachmann B; Henning D; Armstrong R; Boucher DW; Contreras G; Furesz J
Dev Biol Stand; 1984; 57():141-9. PubMed ID: 6084605
[TBL] [Abstract][Full Text] [Related]
18. The use of a monoclonal antibody and of DNA recombinant technology for the localization of a poliovirus neutralization epitope in viral capsid polypeptide VP1.
Bruneau P; van der Werf S; Wychowski C; Siffert O; Girard M
Dev Biol Stand; 1984; 57():177-85. PubMed ID: 6084609
[TBL] [Abstract][Full Text] [Related]
19. Improved distribution of antigenic site specificity of poliovirus-neutralizing antibodies induced by a protease-cleaved immunogen in mice.
Roivainen M; Montagnon B; Chalumeau H; Murray M; Wimmer E; Hovi T
J Virol; 1990 Feb; 64(2):559-62. PubMed ID: 1688625
[TBL] [Abstract][Full Text] [Related]
20. Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies.
Emini EA; Jameson BA; Lewis AJ; Larsen GR; Wimmer E
J Virol; 1982 Sep; 43(3):997-1005. PubMed ID: 6183443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
